Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function

0Citations
Citations of this article
99Readers
Mendeley users who have this article in their library.

Abstract

Chloroquine and hydroxychloroquine have shown promising preliminary results and have been discussed as therapeutic options for patients with Covid-19. Despite the lack of robust evidence demonstrating the benefits and justifying the use of one of these drugs, the final decision is the responsibility of the attending physician and should be individualized and shared, whenever possible. This position statement recommends dosage adjustment for these drugs in the context of renal impairment.

Cite

CITATION STYLE

APA

Moura-Neto, J. A., Misael, A. M., Silva, D. R. da, D’Avila, R., Andreoli, M. C. C., Kraychete, A., … Nascimento, M. M. do. (2020). Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function. Jornal Brasileiro de Nefrologia : ’orgao Oficial de Sociedades Brasileira e Latino-Americana de Nefrologia, 42(2), 49–50. https://doi.org/10.1590/2175-8239-JBN-2020-S113

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free